{"id":1676,"date":"2022-12-21T12:39:03","date_gmt":"2022-12-21T12:39:03","guid":{"rendered":"https:\/\/vacure-conference.net\/?page_id=1676"},"modified":"2024-06-13T12:13:17","modified_gmt":"2024-06-13T12:13:17","slug":"program-wednesday-1-february","status":"publish","type":"page","link":"https:\/\/vacure-conference.net\/index.php\/program-wednesday-1-february\/","title":{"rendered":"Program Wednesday 1 February"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"1676\" class=\"elementor elementor-1676\">\n\t\t\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-899b5fc elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"899b5fc\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-cd5ee74\" data-id=\"cd5ee74\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-dae476c elementor-widget elementor-widget-heading\" data-id=\"dae476c\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.6.5 - 27-04-2022 *\/\n.elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px}<\/style><h2 class=\"elementor-heading-title elementor-size-default\">Program<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-d074b8a elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"d074b8a\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-11bce9e\" data-id=\"11bce9e\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-09e4855 elementor-widget elementor-widget-html\" data-id=\"09e4855\" data-element_type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\n\n<table width=\"601\" cellpadding=\"7\" cellspacing=\"0\">\n\t<col width=\"100\"\/>\n\n\t<col width=\"473\"\/>\n\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" width=\"587\" height=\"34\" valign=\"top\" style=\"border-top: 1px dotted #000000; border-bottom: none; border-left: none; border-right: none; padding-top: 0.08in; padding-bottom: 0in; padding-left: 0in; padding-right: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font color=\"#70ad47\"><font size=\"5\" style=\"font-size: 18pt\"><b>Day\n\t\t\t\t2 <\/b><\/font><\/font><font color=\"#70ad47\"><font size=\"5\" style=\"font-size: 18pt\"><b>\u2502Wednes<\/b><\/font><\/font><font color=\"#70ad47\"><font size=\"5\" style=\"font-size: 18pt\"><b>day\n\t\t\t\t1 February <\/b><\/font><\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" width=\"587\" height=\"15\" bgcolor=\"#d9d9d9\" style=\"background: #d9d9d9; border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"4\" style=\"font-size: 14pt\"><b>KEYNOTE\n\t\t\t\tLECTURE <\/b><\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t <tr>\n\t    <td colspan=\"2\" width=\"587\" height=\"34\" valign=\"top\" style=\"border-top: none; border-bottom: none; border-left: none; border-right: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><i>Chair: Taija M\u00e4kinen<\/i><\/font><\/font><\/font><\/p>\n\t\t\t<\/td> \n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font color=\"#70ad47\"> <font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><b>8.30\n\t\t\t\t\u2013  9.10<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><span lang=\"en-US\">In\n\t\t\t\tsearch of novel ways to modulate the PI3K pathway for therapeutic\n\t\t\t\tbenefit<\/span><font color=\"#000000\"><span lang=\"en-GB\"> <\/span><\/font><\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2\"><font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\">Bart Vanhaesebroeck<\/font> <b>\u2502<\/b> UCL Cancer Institute, London, UK<\/font><\/font><\/p>\n\t\t\t\t\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font color=\"#70ad47\"> <font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><b>9.10\n\t\t\t\t\u2013  9.15<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b>Patient\n\t\t\t\tstory <\/b><\/font><\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" width=\"587\" height=\"15\" bgcolor=\"#d9d9d9\" style=\"background: #d9d9d9; border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"4\" style=\"font-size: 14pt\"><b>SESSION\n\t\t\t\tVENOUS\/LYMPHATIC MALFORMATIONS AND PI3K SIGNALING<\/b><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t <tr>\n\t    <td colspan=\"2\" width=\"587\" height=\"34\" valign=\"top\" style=\"border-top: none; border-bottom: none; border-left: none; border-right: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><i>Chairs: Mariona Graupera and Emmanuel Seront<\/i><\/font><\/font><\/font><\/p>\n\t\t\t<\/td> \n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font color=\"#70ad47\">  <font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><b>9.15\n\t\t\t\t\u2013  9.35<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\">Metabolic\n\t\t\t\tdecisions in vascular growth and differentiation <\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2\"><font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\">Michael\n\t\t\t\tPotente<\/font> <b>\u2502<\/b>VA Cure - Berlin Institute of Health at Charit\u00e9 (BIH), Berlin,\n\t\t\t\tGermany<\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font color=\"#70ad47\">  <font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><b>9.35\n\t\t\t\t\u2013  9.50<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\">Contribution\n\t\t\t\tof mechanical forces from blood flow in neurovascular\n\t\t\t\tarteriovenous malformations <\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2\"><font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\">Nicolas\n\t\t\t\tBaeyens<\/font> <b>\u2502<\/b> ULB, Belgium <\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b> 9.50\n\t\t\t\t\u2013 10.05<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\">Loss of myogenic activity in smooth muscle cells as driver of arterio-venous and lymphatic malformations<\/font><\/font><\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2\"><font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><span lang=\"en-GB\">Michael\n\t\t\t\tOrlich <\/span><\/font><span lang=\"fr-FR\"><b>\u2502 <\/b><\/span><span lang=\"en-GB\">Uppsala\n\t\t\t\tUniversity, Sweden<\/span><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font color=\"#70ad47\">  <font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><b>10.05\n\t\t\t\t\u2013 10.20<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><span lang=\"en-US\">Pathogenic\n\t\t\t\tmechanisms of lymphatic malformations<\/span><span lang=\"en-GB\"> <\/span><\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2\"><font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\">Taija\n\t\t\t\tM\u00e4kinen<\/font> <b>\u2502<\/b> VA Cure \u2013 Uppsala University, Sweden<\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b>10.20\n\t\t\t\t\u2013 10.35<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\">Clonal\n\t\t\t\torigin of Pik3ca-driven lymphatic malformations<\/font><\/font><\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2\"><font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\">Hans\n\t\t\t\tSchoofs<\/font> <b>\u2502<\/b> VA Cure \u2013 Uppsala University, Sweden<\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b>10.35\n\t\t\t\t\u2013 11.05<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b>Coffee\n\t\t\t\tbreak<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b>11.05\n\t\t\t\t\u2013 11.20<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\">Proteasome\n\t\t\t\tInhibitors and Proteostasis Defects in Venous and Lymphatic\n\t\t\t\tMalformations Downstream of PI3K\/mTOR Hyperactivation<\/font><\/font><\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2\"><font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\">Carrie\n\t\t\t\tShawber<\/font> <b>\u2502 <\/b>Columbia University Medical Center, USA<\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b>11.20\n\t\t\t\t\u2013 11.50<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\">Targeted\n\t\t\t\ttherapies in PIK3CA-related vascular anomalies <\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2\"><font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><span lang=\"fr-FR\">Guillaume\n\t\t\t\tCanaud<\/span><\/font><span lang=\"fr-FR\"> <\/span><span lang=\"fr-FR\"><b>\u2502\n\t\t\t\t<\/b><\/span><span lang=\"fr-FR\">H\u00f4pital Necker Enfants Malades and\n\t\t\t\tUniversit\u00e9 Paris Cit\u00e9, Paris, France<\/span><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b>11.50\n\t\t\t\t\u2013 12.05<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\">ART-001,\n\t\t\t\tan orally-available PI3K\u03b1 inhibitor for slow-flow vascular\n\t\t\t\tmalformations: a phase 2 randomized, double-blind trial<\/font><\/font><\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\">Akihiro\n\t\t\t\tFujino<\/font> <b>\u2502 <\/b>National Center for Child Health and\n\t\t\t\tDevelopment, Japan <\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2\"><br\/>\n\n\t\t\t\t<\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" width=\"587\" height=\"15\" bgcolor=\"#d9d9d9\" style=\"background: #d9d9d9; border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"4\" style=\"font-size: 14pt\"><b>POSTER\n\t\t\t\tTEASERS<\/b><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t    \t <tr>\n\t    <td colspan=\"2\" width=\"587\" height=\"34\" valign=\"top\" style=\"border-top: none; border-bottom: none; border-left: none; border-right: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><i>Chairs: Mariona Graupera and Emmanuel Seront<\/i><\/font><\/font><\/font><\/p>\n\t\t\t<\/td> \n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b>12.05\n\t\t\t\t\u2013 12.10<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\">New\n\t\t\t\tcapillary lymphatic endothelial cell subtype as a driver of\n\t\t\t\tlymphatic malformation pathology<\/font><\/font><\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2\"><font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\">Milena\n\t\t\t\tPetkova<\/font> <b>\u2502 <\/b>Uppsala University, Sweden&nbsp;  <\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b>12.10\n\t\t\t\t\u2013 12.15<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#000000\">Immunothrombosis\n\t\t\t\tand vascular heterogeneity in cerebral cavernous malformation <\/font><\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2\"><font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\">Maria\n\t\t\t\tGlobisch<\/font><font color=\"#000000\"> <\/font><b>\u2502 <\/b><font color=\"#000000\">Uppsala\n\t\t\t\tUniversity, Sweden  <\/font><\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><span lang=\"fr-FR\"><b>12.15\n\t\t\t\t\u2013 12.20<\/b><\/span><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#000000\">RASA1\n\t\t\t\tand BRAF variants in a patient with capillary\n\t\t\t\tmalformation-arteriovenous malformation 1 (CM-AVM1) and primary\n\t\t\t\tlymphedema, treated with a MEK inhibitor.<\/font><\/font><\/font><\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2\"><font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><span lang=\"fr-FR\">Isabelle Quere <\/span><\/font><font color=\"#000000\"><span lang=\"fr-FR\"> <\/span><\/font><span lang=\"fr-FR\"><b>\u2502\n\t\t\t\t<\/b><\/span><font color=\"#000000\"><span lang=\"fr-FR\">CHU - University of Montpellier<\/span><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b>12.20\n\t\t\t\t\u2013 13.00 <\/b><\/font><\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b>Lunch\n\t\t\t\t<\/b><\/font><\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" width=\"587\" height=\"15\" bgcolor=\"#d9d9d9\" style=\"background: #d9d9d9; border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"4\" style=\"font-size: 14pt\"><b>POSTER\n\t\t\t\tSESSION<\/b><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b>13.00\n\t\t\t\t\u2013 14.30 <\/b><\/font><\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#000000\">Poster\n\t\t\t\tsession 1<\/font><font color=\"#000000\"> (even numbers + teasers from Tuesday and Wednesday)<\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" width=\"587\" height=\"15\" bgcolor=\"#d9d9d9\" style=\"background: #d9d9d9; border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"4\" style=\"font-size: 14pt\"><b>KEYNOTE\n\t\t\t\tLECTURE <\/b><\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t\t <tr>\n\t    <td colspan=\"2\" width=\"587\" height=\"34\" valign=\"top\" style=\"border-top: none; border-bottom: none; border-left: none; border-right: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><i>Chair: Salim Seyfried<\/i><\/font><\/font><\/font><\/p>\n\t\t\t<\/td> \n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><span lang=\"fr-FR\"><b>14.30\n\t\t\t\t\u2013 15.10<\/b><\/span><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><span lang=\"en-US\">Deciphering\n\t\t\t\tthe complex genomic architecture of moyamoya, an avenue towards\n\t\t\t\tthe pathophysiology of this mysterious cerebral angiopathy<\/span><span lang=\"en-GB\">\n\t\t\t\t<\/span><\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><span lang=\"en-GB\">Elisabeth\n\t\t\t\tTournier-Lasserve<\/span><\/font><span lang=\"en-GB\"> <\/span><span lang=\"fr-FR\"><b>\u2502\n\t\t\t\t<\/b><\/span><span lang=\"en-GB\">Saint Louis Hospital, Paris\n                    - Paris Cit\u00e9 University\n                    <\/span><\/font><\/font><\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2\"><br\/>\n\n\t\t\t\t<\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" width=\"587\" height=\"15\" bgcolor=\"#d9d9d9\" style=\"background: #d9d9d9; border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"4\" style=\"font-size: 14pt\"><b>SESSION\n\t\t\t\tCEREBRAL CAVERNOUS MALFORMATIONS &amp; MAP3K3 SIGNALING<\/b><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t\t <tr>\n\t    <td colspan=\"2\" width=\"587\" height=\"34\" valign=\"top\" style=\"border-top: none; border-bottom: none; border-left: none; border-right: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><i>Chairs: Joyce Bischoff and Bojana Lazovic<\/i><\/font><\/font><\/font><\/p>\n\t\t\t<\/td> \n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b>15.10<\/b><\/font><font color=\"#70ad47\"><i><b>\n\t\t\t\t<\/b><\/i><\/font><font color=\"#70ad47\"><b>\u2013 15.40<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\">\u201cGoing under the skin\u201d \u2013 intravital imaging of disturbed vascular flow and blood clot formation in CCM <\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2\"><font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\">Konstantin G\u00e4ngel   <\/font> <b>\u2502 <\/b>Uppsala University, Sweden      <\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b>15.40<\/b><\/font><font color=\"#70ad47\"><i><b>\n\t\t\t\t<\/b><\/i><\/font><font color=\"#70ad47\"><b>\u2013 15.55<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\">CCM2\n\t\t\t\tloss induces a mechano-dependent endothelial mosaicism <\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2\"><font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><span lang=\"en-GB\">Apeksha\n\t\t\t\tShapeti <\/span><\/font><span lang=\"fr-FR\"><b>\u2502 <\/b><\/span><span lang=\"en-GB\">KU\n\t\t\t\tLeuven, Belgium<\/span><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr>\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b>15.55\n\t\t\t\t\u2013 16.15  <\/b><\/font><\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b>Coffee\n\t\t\t\tbreak<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b>16.15\n\t\t\t\t\u2013 16.30<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\">Hypoxia-induced\n\t\t\t\timmunothrombosis and exacerbation of cerebral cavernous\n\t\t\t\tmalformation disease <\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2\"><font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\">Miguel\n\t\t\t\tA. Lopez-Ramirez<\/font> <b>\u2502 <\/b>University of California, San\n\t\t\t\tDiego, USA <\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b>16.30\n\t\t\t\t\u2013 16.45<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\">Targeting\n\t\t\t\tNETosis in cerebral cavernous malformation<\/font><\/font><\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2\"><font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\">Favour\n\t\t\t\tOnyeogaziri<\/font> <b>\u2502 <\/b>Uppsala University, Sweden<\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b>16.45<\/b><\/font><font color=\"#70ad47\"><b>\n\t\t\t\t\u2013 17.05<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\">Studying\n\t\t\t\tthe role of biomechanics in vascular disease models in zebrafish <\/font><\/font>\n\t\t\t\t<\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2\"><font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\">Salim\n\t\t\t\tSeyfried <\/font><b>\u2502 <\/b>VA Cure \u2013 Potsdam University,\n\t\t\t\tGermany<\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><span lang=\"en-US\"><b>17.05<\/b><\/span><\/font><font color=\"#70ad47\"><span lang=\"en-US\"><b>\n\t\t\t\t\u2013 17.20<\/b><\/span><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\">The\n\t\t\t\tPolycomb Repressive Complex 1 protein Cbx7a activates pathogenic\n\t\t\t\tKlf2 targets in a Zebrafish model of Cerebral Cavernous\n\t\t\t\tMalformations<\/font><\/font><\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2\"><font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><span lang=\"en-US\">Cuong\n\t\t\t\tPham<\/span><\/font><span lang=\"en-US\"> <\/span><span lang=\"en-GB\"><b>\u2502\n\t\t\t\t<\/b><\/span><span lang=\"en-GB\">VA Cure \u2013 Potsdam University,\n\t\t\t\tGermany<\/span><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t\n\t\t<tr valign=\"top\">\n\t\t\t<td width=\"100\" height=\"34\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\"><b>17.20\n\t\t\t\t\u2013 17.50<\/b><\/font><\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t\t<td width=\"473\" style=\"border: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2; margin-bottom: 0in\">\n\t\t\t\t<em><font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><span lang=\"en-GB\"><span style=\"font-style: normal\">How\n\t\t\t\tcan preclinical research help CCM patients: focus on two cases,\n\t\t\t\tpropranolol and atorvastatin<\/span><\/span><\/font><\/font><\/em><\/p>\n\t\t\t\t<p align=\"left\" style=\"orphans: 2; widows: 2\"><font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><font color=\"#70ad47\">Roberto\n\t\t\t\tLatini <\/font><b>\u2502 <\/b>Mario Negri Institute for\n\t\t\t\tPharmacological Research IRCCS, Milan, Italy<\/font><\/font><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" width=\"587\" height=\"34\" valign=\"top\" style=\"border-top: none; border-bottom: 1px dotted #000000; border-left: none; border-right: none; padding: 0in\"><p align=\"left\" style=\"orphans: 2; widows: 2\">\n\t\t\t\t<em><font color=\"#70ad47\"><font face=\"Calibri, serif\"><font size=\"2\" style=\"font-size: 11pt\"><span lang=\"en-GB\"><span style=\"font-style: normal\"><i><b>Dinner\n\t\t\t\ton your own<\/b><\/i><\/span><\/span><\/font><\/font><\/font><\/em><\/p>\n\t\t\t<\/td>\n\t\t<\/tr>\n\t<\/tbody>\n\n<\/table>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Program Day 2 \u2502Wednesday 1 February KEYNOTE LECTURE Chair: Taija M\u00e4kinen 8.30 \u2013 9.10 In search of novel ways to modulate the PI3K pathway for therapeutic benefit Bart Vanhaesebroeck \u2502 UCL Cancer Institute, London, UK 9.10 \u2013 9.15 Patient story SESSION VENOUS\/LYMPHATIC MALFORMATIONS AND PI3K SIGNALING Chairs: Mariona Graupera and Emmanuel Seront 9.15 \u2013 9.35 &hellip;<\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/vacure-conference.net\/index.php\/program-wednesday-1-february\/\"> <span class=\"screen-reader-text\">Program Wednesday 1 February<\/span> Read More &raquo;<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-global-header-display":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":""},"class_list":["post-1676","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/vacure-conference.net\/index.php\/wp-json\/wp\/v2\/pages\/1676","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vacure-conference.net\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/vacure-conference.net\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/vacure-conference.net\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/vacure-conference.net\/index.php\/wp-json\/wp\/v2\/comments?post=1676"}],"version-history":[{"count":18,"href":"https:\/\/vacure-conference.net\/index.php\/wp-json\/wp\/v2\/pages\/1676\/revisions"}],"predecessor-version":[{"id":2269,"href":"https:\/\/vacure-conference.net\/index.php\/wp-json\/wp\/v2\/pages\/1676\/revisions\/2269"}],"wp:attachment":[{"href":"https:\/\/vacure-conference.net\/index.php\/wp-json\/wp\/v2\/media?parent=1676"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}